Takeda Pharmaceutical
285 hedge funds and large institutions have $753M invested in Takeda Pharmaceutical in 2022 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 96 increasing their positions, 69 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
285
Holders Change
-11
Holders Change %
-3.72%
% of All Funds
4.51%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
41
Increased
96
Reduced
69
Closed
48
Calls
$36.6M
Puts
$6.22M
Net Calls
+$30.4M
Net Calls Change
-$17.9M
Top Buyers
| 1 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$12.3M |
| 2 |
BlackRock
New York
|
+$12.1M |
| 3 |
Millennium Management
New York
|
+$9.04M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$7.53M |
| 5 |
Goldman Sachs
New York
|
+$7.3M |
Top Sellers
| 1 |
Citigroup
New York
|
-$111M |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$107M |
| 3 |
CFM
Capricorn Fund Managers
London,
United Kingdom
|
-$21.4M |
| 4 |
Wells Fargo
San Francisco,
California
|
-$13.7M |
| 5 |
HT
HAP Trading
New York
|
-$10.8M |
